article · Middle East Journal of Medical Genetics
Background: Merely 2% of pregnant mothers experience two consecutive miscarriages, and as many as 50% of patients suffering from Recurrent Pregnancy Loss (RPL) lack a definitive cause for their condition. The CTLA-4 gene is located in band q33 on chromosome 2 of the human genome, is approximately 6.2 kilobases long, and is composed of 3 introns and 4 exons. In decidual and peripheral dendritic cells, it is expressed on human placental regulatory T (Treg) cells. Human miscarriages were associated with a downregulation of Treg cells and CTLA-4 expression in decidual and peripheral lymphocytes. The purpose of our analysis was to determine whether the CTLA-4 +49A/G (rs231775) & (rs3087243) gene polymorphism and unexplained RPL were related. Subjects and Methods: This case-control study included women with RPL were contrasted with healthy females at the age of motherhood. The study was conducted at the National Research Centre (Clinical Genetics Department -Human Cytogenetic Department - Molecular Genetics and Enzymology Department) in collaboration with Benha Faculty of Medicine (Clinical and Chemical Pathology Department).Results: Considering AG is the reference haplotype, no significant association was found between CTLA-4 rs231775-rs3087243 haplotypes with number of abortions. rs231775 AG+GG was considered a protective predictor, while rs3087243 GA+AA was considered a risky predictor of susceptibility to spontaneous recurrent abortion in uni- and multivariable analyses. Conclusion: Our study revealed that a significant correlation was discovered between the CTLA-4 gene rs231775 AG, GG genotypes, G allele, rs231775- rs3087243 GG haplotype with protective effect against RPL. Whereas, a significant correlation was discovered between the CTLA-4 gene rs3087243 GA, AA genotypes, A allele AA haplotype and RPL risk.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.21608/mxe.2024.39458
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.